We demonstrate that MNs derived from iPSCs obtained from healthy individuals or patients harbouring TARDBP or C9ORF72 ALS-causing mutations are able to develop appropriate physiological properties. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.